VHT logo

VHTVanguard Health Care ETF

$284.13
$0.75
(0.27%)
Today
Closed $284.13
$1.62
(0.57%)
After Hours
Updated: 07:58 PM EDT
Vol408,938.00
52W High$298.61
52W Low$237.23
32

Bearish Sentiment

How do you feel about VHT?

News
all
press releases
Vanguard (VHT) Vs. Simplify (PINK): Which Healthcare ETF Is the Better Buy for Investors?
Key PointsVanguard Health Care ETF offers a much lower expense ratio and a higher trailing dividend yield than Simplify Health Care ETF...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet
LLY's $4B vaccine push is boosting interest in healthcare ETFs like IHE with heavy exposure to the drugmaker.
Zacks
News Placeholder
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost
Key PointsVanguard Health Care ETF offers a significantly lower expense ratio and higher dividend yield compared to State Street SPDR S&P Biotech ETF...
Nasdaq News: Markets
News Placeholder
US-Iran Ceasefire Hopes Fade: ETF Strategies to Play
U.S.-Iran tensions rise as Hormuz risks grow. Markets turn volatile -- dividend, low-beta, and defensive ETFs may help cushion portfolios.
Zacks
News Placeholder
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.
Zacks
News Placeholder
Should You Invest in the Vanguard Health Care Index Fund ETF Shares (VHT)?
Sector ETF report for VHT
Zacks
News Placeholder
MLTX Stock Garners Retail Attention On Buyout Speculation, Positive Skin Condition Trial Data
A Stocktwits user highlighted optimism for a buyout for MoonLake, highlighting other recent mergers and acquisitions in the pharma industry, such as Biogen’s buyout of Apellis.
Stocktwits
News Placeholder
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
Eli Lilly's $2.75B AI drug deal with Insilico spotlights healthcare ETFs as investors seek diversified exposure to the fast-growing AI-driven pharma space.
Zacks
News Placeholder
Stagflation Scare? ETFs May Help Protect Your Portfolio
Are stagflation risks returning as oil-driven inflation rises amid Middle East tensions? Here's how ETFs can help defend portfolios.
Zacks
News Placeholder
OCGN Stock Tanks After Gene Therapy Trial Update — What Did Ocugen Announce?
Ocugen said 12-month Phase 2 trial data showed its drug OCU410 significantly reduced lesion growth at the dose planned for Phase 3.
Stocktwits
<
1
2
...
>

Advertisement|Remove ads.